For the readers interested in the stock health of Kintara Therapeutics Inc. (KTRA). It is currently valued at $1.49. When the transactions were called off in the previous session, Stock hit the highs of $1.38, after setting-off with the price of $1.29. Company’s stock value dipped to $1.17 during the trading on the day. When the trading was stopped its value was $1.36.
Recently in News on September 1, 2020, Kintara Therapeutics Completes Final Closing of Previously Announced Private Placement For an Aggregate of $25 Million. – Launches Strategic Growth Initiative of Expanded Late-stage Oncology Pipeline -. You can read further details here
Kintara Therapeutics Inc. had a pretty favorable run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $1.6000 on 09/09/20, with the lowest value was $0.3800 for the same time period, recorded on 03/26/20.
Kintara Therapeutics Inc. (KTRA) full year performance was 113.33%
Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Kintara Therapeutics Inc. shares are logging -2.61% during the 52-week period from high price, and 292.11% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $0.38 and $1.53.
The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 1147906 for the day, which was evidently higher, when compared to the average daily volumes of the shares.
When it comes to the year-to-date metrics, the Kintara Therapeutics Inc. (KTRA) recorded performance in the market was 97.19%, having the revenues showcasing 9.68% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 31.46M, as it employees total of 4 workers.
Specialists analysis on Kintara Therapeutics Inc. (KTRA)
During the last month, 0 analysts gave the Kintara Therapeutics Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.
According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 0.9187, with a change in the price was noted +1.0038. In a similar fashion, Kintara Therapeutics Inc. posted a movement of +194.46% for the period of last 100 days, recording 847,995 in trading volumes.
Trends and Technical analysis: Kintara Therapeutics Inc. (KTRA)
Raw Stochastic average of Kintara Therapeutics Inc. in the period of last 50 days is set at 91.92%. The result represents improvement in oppose to Raw Stochastic average for the period of the last 20 days, recording 85.96%. In the last 20 days, the company’s Stochastic %K was 67.32% and its Stochastic %D was recorded 57.52%.
Now, considering the stocks previous presentation, multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be pessimistic, given the fact the metric is recording 97.19%. Additionally, trading for the stock in the period of the last six months notably improved by 180.35%, alongside a boost of 113.33% for the period of the last 12 months. The shares increased approximately by 13.33% in the 7-day charts and went down by 28.30% in the period of the last 30 days. Common stock shares were driven by 9.68% during last recorded quarter.